|
|
RFID in the Life Science Supply Chain: Industry Sentiment and Lessons LearnedPublished by: IDC Published: Apr. 4, 2006 - 20 Pages Table of ContentsTable of Contents In This Perspective Methodology Brief Description of the Solution Research Methodology Situation Overview Business Need lESSONS LearnED Key Takeaways RFID-Enabled e-Pedigree Is Attainable RFID Must Be Accompanied by Stricter Laws, Regulations, and Penalties RFID Is an Open-Face Card Game Further Education of Consumers Regarding Privacy Is Required Figure: Consumer Concern About Personal Medical Information Privacy and Confidentiality Integrating Tags into Labels or Bottles Prior to the Pharmaceutical Manufacturer Is a Must Trial and Error Is Required HF Will Solidify as the Item-Level Standard Patient Safety Comes Before ROI RFID Will Not Increase Consumer Drug Prices - Yet FDA Must Mandate RFID Adoption Current Pilots across the Value Chain Pharmaceutical Manufacturers Pfizer Distributors/Wholesalers FFF Enterprises Retailers/Pharmacies A Leading Retail Pharmacy Cold Chain Distribution A Leading Pharmaceutical Company Future Outlook Figure: Respondent Company Current Involvement with RFID Figure: Respondent Company Time Expectations Surrounding Tagging Levels Learn More Related Research AbstractSeveral radio frequency identification (RFID) pilot programs and educational initiatives have been underway for months, assessing the technology's capabilities and related process change requirements. This Health Industry Insights document outlines many of the lessons that have been learned regarding RFID technology by manufacturers, distributors, and retail pharmacies across the pharmaceutical supply chain and discusses industry sentiment regarding RFID adoption. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||